
Addyi, the controversial prescription medication to treat low libido in women, hit pharmacy shelves Saturday coinciding with Sweetest Day, a holiday of romance.
Flibanserin, sold commercially as Addyi, is the first drug approved by the U.S. Food and Drug Administration to treat premenopausal women whose low libido does not stem from a medical or psychiatric condition, but from a lack of desire called hypoactive sexual desire disorder. The once-daily, non-hormonal pill is only available with a prescription.
The drug has been dubbed the "female Viagra" but does not work in the same way. Viagra works by increasing blood flow to the male genitals. Addyi targets brain chemicals to increase desire. It includes a black-boxed warning against taking the drug while drinking alcohol or using other types of drugs. Women with liver problems also should not take the drug.
Dr. Holly Thacker from the Cleveland Clinic said Addyi "provides an additional, helpful option for women across the country who experience sexual dysfunction."
"It doesn't treat all sexual dysfunction, it won't help all women with sexual problems, but it will have a role in the therapy," Thacker said. "Just like with any medication -- adult women in conjunction with their physician can make an informed decision about whether this is an appropriate therapy for them."
Addyi was twice rejected for approval by the FDA, partially due to side effects that include nausea and fainting. Some medical experts have said the drug has not been shown to be effective.
"Not one person in the studies that have been done has actually reported an increase in sexual desire," psychotherapist Keesha Ewers, founder and chief medical officer of the Functional Sexology Institute, said. "What has been reported is a decrease in the distress that is felt about lack of sexual desire."
Cindy Whitehead, CEO of drug maker Sprout Pharmaceuticals, said, "Women are pretty clear they're not on-demand creatures. The media loves to call this female Viagra, but that's the point at which we start the real conversation on how this is different for women. Desire is a state. This goes back to making sure those brain chemicals are aligned in a way that allows desire to take hold."
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor